Latest stories on NRSN
Neurosense Therapeutics Ltd trading halted, news pending
The Fly48 · neutralgeneral
NeuroSense to Present at H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire56 · neutralgeneral
NeuroSense Therapeutics to Enact 1-for-20 Reverse Share Split on Nasdaq
TipRanks25 · bearishgeneral
NeuroSense initiated with a Buy at H.C. Wainwright
The Fly61 · neutralanalyst
NeuroSense announces redesigned development plan for PrimeC
The Fly56 · neutralproduct/pr
NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS
StockTitan67 · bullishproduct/pr
NeuroSense CEO Details Phase 3 ALS Trial Plans, Canada Filing and Nasdaq Compliance Efforts
TipRanks56 · neutralproduct/pr
NeuroSense Issues CEO Letter to Shareholders
PR Newswire50 · neutralgeneral
NeuroSense Advances PrimeC Toward December 2026 Health Canada Filing After Completing Pre-NDS Process
TipRanks63 · neutralproduct/pr
Neurosense Sees December 2026 As Filing Date For Nds For Primec
The Fly55 · neutralgeneral
NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada
PR Newswire67 · bullishproduct/pr
NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS
StockTitan67 · bullishproduct/pr
NeuroSense to Participate in Roth-Hosted KOL Webinar on the Future of ALS Treatment: "A Quest to Outrun ALS" | NRSN Stock News
StockTitan56 · neutralproduct/pr
NeuroSense Hits Key TDP-43 Endpoint in Phase 2b ALS Trial, Advances Toward Phase 3
TipRanks73 · bullishproduct/pr
NeuroSense Posts Positive Phase 2 Biomarker Signals for PrimeC in Alzheimer’s Trial
TipRanks73 · bullishproduct/pr
EverythingALS to Host NeuroSense in a Community Event Named: PrimeC - Connecting the Dots | NRSN Stock News
StockTitan56 · neutralproduct/pr
NeuroSense Secures South Korean Patent for ALS Drug Candidate PrimeC
TipRanks67 · bullishproduct/pr
NeuroSense Granted South Korean Patent Covering PrimeC Composition for ALS | NRSN Stock News
StockTitan67 · bullishproduct/pr
NeuroSense Therapeutics Wins Key Japanese Patent for ALS Drug PrimeC
TipRanks67 · bullishproduct/pr
NeuroSense Therapeutics Receives Japanese Patent Grant for PrimeC Novel Composition
PR Newswire63 · neutralproduct/pr
NeuroSense Therapeutics Receives Japanese Patent Grant for PrimeC Novel Composition | NRSN Stock News
StockTitan63 · neutralproduct/pr
NeuroSense Therapeutics Advances Canadian Regulatory Talks on ALS Drug PrimeC
TipRanks56 · neutralproduct/pr